The market for biological age testing, which estimates cellular wear and tear rather than chronological age, is experiencing significant growth, projected to reach $3.09 billion globally by 2033.
Despite the availability of direct-to-consumer kits, experts advise caution regarding their current utility for general consumers, emphasizing that these tests are primarily research tools and require further clinical validation.
Understanding Biological Age
Biological age, also referred to as epigenetic age, reflects the physiological condition of an individual's cells and tissues, contrasting with chronological age, which is based on years since birth. This biological metric is influenced by a combination of genetics, lifestyle choices, and medical history.
Dr. Douglas Vaughan, director of the Potocsnak Longevity Institute at Northwestern University's Feinberg School of Medicine, highlights a key distinction:
While chronological age advances steadily, biological age can change over time.
Measurement Methods and Market Dynamics
Scientists have developed methods to estimate biological age, predominantly through epigenetic clocks. These clocks measure DNA methylation, a biochemical process that regulates gene activity. Direct-to-consumer test kits utilizing these methods are available online, with prices ranging between $299 and $499.
The global biological age testing market was valued at $1.28 billion in 2024 and is forecast to grow to $3.09 billion by 2033.
Key examples of epigenetic clocks include:
- PhenoAge: Designed to estimate biological age.
- GrimAge: Formulated to predict the probability of mortality within a year.
- DunedinPACE: Measures the rate of biological aging, with a value of 1 indicating an average aging rate. Values between 0.5 and 1.5 are common.
Steve Horvath, a professor at UCLA’s David Geffen School of Medicine and a developer of early epigenetic clocks including the Horvath Clock in 2013, contributed to the development of markers like PhenoAge and GrimAge.
Expert Perspectives and Cautions
Experts in the field advise caution regarding the widespread use of biological age tests by general consumers.
Current Utility for Consumers
Dr. Vaughan states that the measurement of epigenetic age is "not prime-time yet for general consumers," citing uncertainty about the data's value. Daniel Belsky, an associate professor of epidemiology at Columbia University, further explains that epigenetic clocks are largely statistical constructs based on algorithms, without direct biological reference.
Research vs. Clinical Use
Professor Horvath emphasizes that the primary application for these clocks remains in laboratory research, with clinical validation still in progress. He expressed hope for their future integration into routine medical exams.
Interpretation Limitations
Christopher Hine, principal investigator at Cleveland Clinic Research, clarifies that biological age tests provide a snapshot of health at a specific moment. Results can be influenced by temporary factors, such as illness. He suggests that multiple measurements over time offer a more comprehensive understanding of an individual's aging trajectory. Hine also noted that these tests are not intended to diagnose disease.
Biological age tests provide a snapshot of health at a specific moment. Multiple measurements over time offer a more comprehensive understanding of an individual's aging trajectory.
Recommendations for Consumers
Medical professionals and researchers recommend a cautious approach to interpreting biological age test results:
Holistic Health Assessment
Dr. Vaughan advises against relying solely on biological age results. He stresses the continued importance of traditional health markers like cholesterol and blood pressure, noting that biological age alone can be misleading despite its potential to refine disease risk prediction.
Avoid Drastic Actions
Experts, including Dr. Vaughan and Hine, caution against making drastic lifestyle changes, self-medicating with supplements, or engaging in extreme exercise based solely on a single test result.
They recommend consulting a medical professional for guidance.
Malleability of Results
Dr. Vaughan indicates that chemical changes to DNA are malleable. Research has linked tobacco smoking to accelerated biological aging, while daily multivitamin intake has been associated with slower aging in older adults.
Varying Information
Belsky notes that different epigenetic clocks can provide differing information, necessitating cautious interpretation of results.